LB PHARMACEUTICALS
LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed in the United States. Its approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs
LB PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.lbpharma.us
Total Employee:
11+
Status:
Active
Contact:
646-588-8175
Email Addresses:
[email protected]
Total Funding:
18.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Domain Not Resolving Apache
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Employees Featured
Founder
Official Site Inspections
http://www.lbpharma.us Semrush global rank: 5.95 M Semrush visits lastest month: 1.38 K
- Host name: lbpharma.tempurl.host
- IP address: 64.176.202.58
- Location: Andover United States
- Latitude: 42.6508
- Longitude: -71.1607
- Metro Code: 506
- Timezone: America/New_York
- Postal: 01810
More informations about "LB Pharmaceuticals"
LB Pharmaceuticals – New hope for patients suffering from …
About Us. We are a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases. Learn More. For Patients & Providers. We are …See details»
Leadership – LB Pharmaceuticals
Contact Us; Leadership. Our management and leadership are composed of individuals with extensive experience in the discovery, development, and commercialization of …See details»
About Us – LB Pharmaceuticals
About Us Founded in 2015, LB Pharmaceuticals Inc, is committed to developing innovative therapies for neuropsychiatric diseases, including schizophrenia. Our lead product candidate, …See details»
LB Pharmaceuticals - Crunchbase Company Profile
Contact Email [email protected] Phone Number 212-605-0230 LB Pharmaceuticals is a development stage life sciences company devoted to …See details»
LB Pharmaceuticals Inc. - LinkedIn
LB Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of schizophrenia. Our lead drug candidate is a second-generation antipsychotic and …See details»
LB Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for LB Pharmaceuticals, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
LB Pharmaceuticals - Company Profile - Tracxn
Jan 8, 2025 Website: lbpharma.us; Phone Number: +1 ***** Key Metrics. Total Funding. $130M in 6 rounds. Latest Funding Round. Series C, Aug 29, 2023, $111M. Investors. Tarnagulla Ventures. ... United States. Is LB …See details»
UPDATE – LB Pharmaceuticals Announces Presentation at the 43rd …
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric …See details»
LB Pharmaceuticals - Craft
LB Pharmaceuticals is a life sciences company focused on developing treatments for CNS disorders. It offers LB-102 (also known as N-methyl amisulpride), a proprietary variant of …See details»
LB Pharmaceuticals Company Profile | Management and
LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but …See details»
CORPORATE PRESENTATION JUNE 2020 - lbpharma.us
MANAGEMENT TEAM Andrew Vaino, Ph.D., Chief Science Officer o Former VP of R&D at Retrophin, Inc. o Invented and brought drug to treat PKAN (RE-024) from idea to dosing in …See details»
LB Pharmaceuticals - PitchBook
LB Pharmaceuticals General Information Description. Operator of a drug development company intended to treat schizophrenia in patients. The company uses a pro-drug approach to change …See details»
LB Pharmaceuticals Announces Positive Topline Results from …
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of psychiatric …See details»
LB Pharmaceuticals Presents Results of Dopamine ... - Business Wire
Oct 4, 2021 More information about LB-102 and LB Pharmaceuticals may be found on our corporate website located at www.LBPharma.us Contacts Zachary Prensky, President & CEO …See details»
LB Pharmaceuticals - Overview, News & Similar companies
LB Pharmaceuticals contact info: Phone number: (646) 588-8175 Website: www.lbpharma.us What does LB Pharmaceuticals do? LB Pharmaceuticals is a development stage life sciences …See details»
INVESTOR PRESENTATION JULY 2022 - lbpharma.us
CNS-focused biotech building a pipeline of potential best-in-class therapies for the US market Lead asset, LB-102, is a novel benzamide leveraging the demonstrated efficacy and safety of …See details»
UPDATE – LB Pharmaceuticals Announces Presentation at the
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric …See details»
LB Pharmaceuticals Announces Key Executive Appointments to
1 day ago Gad Soffer Joins as Chief Business Officer and Richard Silva, Ph.D., as Senior Vice President of Technical Operations. NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- LB …See details»
CORPORATE PRESENTATION FEBRUARY 2021 - lbpharma.us
• US composition of matter patents covering LB-102 granted in 2019 (Patent Numbers: 10,259,786 and 10,167,256) ‒ PCT application and 11 foreign patent applications pending • …See details»
LB Pharmaceuticals Announces Key Executive ... - Markets Insider
19 hours ago NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing novel therapies for t...See details»